Search
for
Sort by
Research 30 of 68
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- The Charnoly body as a universal biomarker of cell injury
- Parkinson's disease and skin
- Promoting axonal regeneration through exosomes: An update of recent findings on exosomal PTEN and mTOR modifiers
- Genetic determinants of skin ageing: a systematic review and meta-analysis of genome-wide association studies and candidate genes
- Drugs that affect autonomic functions or the extrapyramidal system
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
- Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
- In This Issue
- Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
- Combined drug triads for synergic neuroprotection in retinal degeneration
- Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases
- Transcriptomic landscape of early hair follicle and epidermal development
- Hair glucocorticoid levels in Parkinson’s disease
- Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
- Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease
- Aqueous Extract of Bacopa procumbens and the NAPEL Formulation Mitigate MPTP-Induced Neurotoxicity via Nrf2/HSF1/HIF-1α Signaling in a Parkinson’s Disease Model
- Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends
- Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran
- Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α‐synuclein triplication (Iowa kindred)